The renin-angiotensin system (RAS) has a relevant role in COVID-19, as the virus will enter
host's cells via the angiotensin-converting enzyme 2 (ACE2); RAS disequilibrium might also
play a key role in the modulation of the inflammatory response that characterizes the lung
involvement. Angiotensin-(1-7) is a peptide that could be altered in COVID-19 patient and its
supplementation may potentially helpful in this setting.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Erasme University Hospital
Collaborators:
Angitec Federal University of Minas Gerais Fonds Erasme pour la Recherche Medicale